Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AI Technology Group ( (AIPG) ) just unveiled an update.
On January 27, 2026, AI Technology Group Inc., AVM Biotechnology Inc. and Biomed 360 Solutions Corp. amended their previously signed Agreement and Plan of Merger, originally filed on September 15, 2025, to update investment obligations and extend the merger timeline in light of financial audit requirements. The revised terms confirm that $1 million in Tranche 1 loans was provided by August 1, 2025 and $1 million of a $4 million Tranche 2 was funded by November 20, 2025, while scheduling the remaining three $1 million Tranche 2 investments for February 28, April 30 and June 30, 2026, all convertible into parent shares at $2.50 per share and accruing 10% simple annual interest until conversion. The parties also set Tranche 3 funding at a minimum of $10 million and a maximum of $25 million in additional convertible loans at the same share-conversion rate and interest structure, and extended the merger closing date from March 31, 2026 to July 26, 2026, signaling a longer but more structured financing and closing pathway that clarifies capital commitments and timing for stakeholders.
More about AI Technology Group
AI Technology Group Inc. operates as a parent entity pursuing a merger with biotechnology-focused companies AVM Biotechnology Inc. and Biomed 360 Solutions Corp., indicating a strategic move into or expansion within the biotech and life sciences solutions space.
Average Trading Volume: 191
Technical Sentiment Signal: Buy
Current Market Cap: $4.01M
For a thorough assessment of AIPG stock, go to TipRanks’ Stock Analysis page.